Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer

NCT00814788 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Bicalutamide
DRUG: Everolimus

Sponsor

University of California, Davis

Collaborators

[object Object]